Drugs

FDA Approves New Drug to Treat Travelers’ Diarrhea

November 18, 2018

The Food and Drug Administration (FDA) announces it has approved Aemcolo (rifamycin), an antibacterial drug indicated for the treatment of adult patients with travelers’ diarrhea caused by noninvasive strains of Escherichia coli (E. coli), not complicated by fever or blood in the stool.

FDA Approves New Drug to Treat Influenza

October 25, 2018

The Food and Drug Administration (FDA) announces it has approved Xofluza (baloxavir marboxil) for the treatment of acute uncomplicated influenza (flu) in patients 12 years of age and older who have been symptomatic for no more than 48 hours.

Stealth Drug Fights Resistant Bacteria

September 27, 2018

The lack of new antibiotics is among the most critical challenges facing medicine. Researchers have been on the hunt for new drugs to combat "superbugs" that cannot be penetrated by current antibiotics.

Pages